The Xenopus tadpole: an in vivo model to screen drugs favoring remyelination - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Multiple Sclerosis Journal Année : 2018

The Xenopus tadpole: an in vivo model to screen drugs favoring remyelination

Résumé

Background: In multiple sclerosis, development of screening tools for remyelination-promoting molecules is timely. Objective: A Xenopus transgenic line allowing conditional ablation of myelinating oligodendrocytes has been adapted for in vivo screening of remyelination-favoring molecules. Methods: In this transgenic, the green fluorescent protein reporter is fused to E. coli nitroreductase and expressed specifically in myelinating oligodendrocytes. Nitroreductase converts the innocuous pro-drug metronidazole to a cytotoxin. Spontaneous remyelination occurs after metronidazole-induced demyelinating responses. As tadpoles are transparent, these events can be monitored in vivo and quantified. At the end of metronidazole-induced demyelination, tadpoles were screened in water containing the compounds tested. After 72 h, remyelination was assayed by counting numbers of oligodendrocytes per optic nerve. Results: Among a battery of molecules tested, siponimod, a dual agonist of sphingosine-1-phosphate receptor 1 and 5, was among the most efficient favoring remyelination. Crispr/cas9 gene editing showed that the promyelinating effect of siponimod involves the sphingosine-1-phosphate receptor 5. Conclusion: This Xenopus transgenic line constitutes a simple in vivo screening platform for myelin repair therapeutics. We validated several known promyelinating compounds and demonstrated that the strong remyelinating efficacy of siponimod implicates the sphingosine-1-phosphate receptor 5.
Fichier principal
Vignette du fichier
ZALC_Bernard.pdf (837.36 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01912256 , version 1 (05-11-2018)

Identifiants

Citer

Abdelkrim Mannioui, Quentin Vauzanges, Jean Baptiste Fini, Esther Henriet, Somya Sekizar, et al.. The Xenopus tadpole: an in vivo model to screen drugs favoring remyelination. Multiple Sclerosis Journal, 2018, 24 (11), pp.1421 - 1432. ⟨10.1177/1352458517721355⟩. ⟨hal-01912256⟩
86 Consultations
561 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More